We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novoheart Holdings Inc | TSXV:NVH | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.53 | 0.52 | 0.72 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
TORONTO, Oct. 12, 2017 /CNW/ - Professor Ronald Li, CEO & Scientific Co-Founder, Novoheart Holdings Inc., joined Rob Peterman, Vice-President, Global Business Development, TMX Group, to open the market. Novoheart is a global stem cell biotechnology company dedicated to human heart engineering with offices in Vancouver, British Columbia, the United States and Hong Kong. Novoheart Holdings Inc. commenced trading on TSX Venture Exchange on October 3, 2017.
SOURCE TMX Group Limited
Copyright 2017 Canada NewsWire
1 Year Novoheart Chart |
1 Month Novoheart Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
